CLYYF   $0.6049  4.29% Market Closed

Celyad Oncology SA
Total Cash 6.23M
totalCashPerShare 0.15
EBITDA -7.44M
Total Debt 989.00K
quickRatio 3.027
currentRatio 3.585
Total Revenue 72.00K
debtToEquity 30.291
Revenue/Share 0.002
ROA -0.38868
ROE -3.61905
grossProfits
freeCashflow -7.88M
operatingCashflow -9.70M
earningsGrowth
revenueGrowth -0.682
grossMargins 0.52778
ebitdaMargins 0.0
operatingMargins -220.2857
profitMargins 0.0
enterpriseValue 4.91M
forwardPE
floatShares 14.14M
sharesOutstanding 41.43M
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.11%
heldPercentInstitutions 0.55%
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue 0.079
Price To Book help_outline 3.10
earningsQuarterlyGrowth
netIncomeToCommon -7.75M
trailingEps -1.49%
forwardEps
enterpriseToEbitda -0.66
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 2
lastUpdated Oct. 17, 2024, 2:03 a.m.